Catalyst Pharmaceutical (CPRX) Files $11.5M Common Shelf
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Up)Join SI Premium – FREE
Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $11.5 million of its Common Stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- INmune Bio (INMB) Prices 986K Share Offering at $9.84/sh
- Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
- Eyenovia Inc (EYEN) Provides Clinical and Scientific Update on Mydcombi and Clobetasol
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
